USFDA granted approval to Aurobindo Pharma for Flucytosine Capsules

Aurobindo Pharma received its final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg.

Flucytosine Capsules are used for the treatment of serious infections caused by susceptible strains of Candida and Cryptococcus. The Capsules are a generic version of Bausch Health’s Ancobon Capsules and the capsules will be launched in June 2020.

A total of 429 ANDA approvals has been granted to Aurobindo (401 Final approvals including 23 from Aurolife Pharma LLC and 28 tentative approvals) from USFDA.

  • Related Posts

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Ranchi: The Jharkhand High Court on February 4 ordered the registration of a first information report (FIR) in a case where five children were infected with HIV after getting blood transfusions…

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    New Delhi: In an effective and decisive action, the Anti-Narcotics Task Force (ANTF) of the Crime Branch has successfully dismantled a major Narco-syndicate indulged in supply of contraband medicines. This…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

    Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

    BDMAI’s e-marketing portal to promote Indian pharma products and services

    BDMAI’s e-marketing portal to promote Indian pharma products and services

    FIR against pharma dealer for supplying dubious snake antidote to govt

    FIR against pharma dealer for supplying dubious snake antidote to govt